Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy

Toll-like receptors (TLRs) have first been characterized for their capacity to detect conserved microbial components like lipopolysaccharide (LPS) and double-stranded RNA, resulting in the elicitation of potent (innate) immune responses against invading pathogens. More recently, TLRs have also been...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Vacchelli, Erika, Galluzzi, Lorenzo, Eggermont, Alexander, Fridman, Wolf Hervé, Galon, Jerome, Sautès-Fridman, Catherine, Tartour, Eric, Zitvogel, Laurence, Kroemer, Guido
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2012
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3489745/
https://ncbi.nlm.nih.gov/pubmed/23162757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.20931
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars